Clin Pharmacokinet 58(9):11931203 Barrington P, Chien JY, Showalter HDH, Schneck K, Cui S, Tibaldi F et al (2011) A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes
FAQs What causes a weight loss plateau on Semaglutide
Several practical factors may explain fatigue during GLP-1 therapy: Reduced food intake due to appetite suppression can lead to lower energy consumption Gastrointestinal side effects like nausea can be physically draining Adaptation to metabolic changes as your body adjusts to the medication For people with diabetes who take insulin or sulfonylureas (like gliclazide) alongside GLP-1 medications, low blood glucose (hypoglycaemia) may cause fatigue
GLP-1 class medications have recently grown in popularity
Similar content being viewed by others Background Septic shock is the leading cause of death in the intensive care unit (ICU), and despite increased knowledge about the pathogenesis of sepsis, its mortality rate remains high, approximately 20 to 80% [1,2,3]